Amarin Corporation PLC (AMRN) Reports Fourth Quarter And Year-End 2013 Financial Results And Provides Update On Operations
2/28/2014 9:22:12 AM
BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late stage biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the quarter and year ended December 31, 2013, and provided an update on company operations.
Help employers find you! Check out all the jobs and post your resume.
comments powered by